
The Luzón Foundation is organizing a new meeting in Zaragoza to advance research into ALS.
7 May 2026
The IIS Aragón is promoting a conference on male breast cancer to advance visibility, diagnosis and research
11 May 2026The session brought together professionals and representatives from the healthcare sector in Zaragoza to reflect on the impact of the new European and national framework on innovation management and health outcomes
The Aragon Health Research Institute (IIS Aragon) and Menarini Stemline They celebrated the past April 29 in Zaragoza the V IIS Aragón-Menarini Classroom Conference, a date focused on the new framework for Health Technology Assessment and its impact on the National system of health.
The inauguration was attended by Ana Cristina Castillo, managing director of Aragonese Health Service, and Mª Ángeles ÁlcutenThe day was coordinated by Ana Cristina Bandrés Liso y José María Gimeno Feliú, and brought together professionals and representatives from the healthcare sector with the aim of analyzing the challenges and opportunities posed by this new regulatory context.
During the main table discussion, which included José Luis Poveda, César Hernández, Elena Gras, Reyes Abad, Pablo Crespo and Soledad IsernSome of the weaknesses of the current model were openly addressed, especially in terms of coordination, timing, and alignment between assessment, funding, and clinical practiceAt the same time, the debate highlighted the opportunity presented by the new European and national framework to move towards a more integrated system.
In this sense, there was broad consensus regarding the need to strengthen the coordinated work between administrations, professionals and the rest of the actors involvedThe shared commitment to move forward in this direction was also highlighted, so that the regulatory change translates into... real improvements in innovation management and health outcomes.
The session also included a specific section on the role of the new technologies in drug management, with special attention to the development of tools based on Artificial intelligence applied to pharmacotherapeutic practice.
To close the day, the awards ceremony was held. First Call for Entries for the Aula IIS Aragón–Menarini AwardsThese awards recognize the contribution of professionals to the improvement of the healthcare system through good practices in healthcare innovation.
El first prize It was for the project “Implementation of an AI agent ecosystem for the rigorous, traceable and standardized automation of CEMAE reports”, a system of agentic artificial intelligence aimed at automating the Drug evaluation in Oncohematologytransforming the process into something more efficient and rigorous.
In addition, several were granted second prizes to projects focused on the safe use of health data, the digital therapeutic education and improvement of care pathways. Among them, HealthData@MAD-R&I®, a platform that optimizes the safe use of health data; Digital Therapeutic Education in Breast Cancer, an initiative that promotes patient empowerment through artificial intelligence and gamification; and Optimization of the Care Pathway in Breast Cancer, an innovative model of shared monitoring between oncology and pharmacy.




